Digital PCR and Real-time PCR (qPCR) Market by Technology (qPCR, dPCR), Product (Instrument, Reagent), Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic), End User (Hospital, Diagnostic Center, Academia, CRO) - Forecast to 2022
“The global digital PCR and real-time (qPCR) market projected to grow at a CAGR of 8.9%.”
The global dPCR and qPCR market is estimated to grow at a CAGR of 8.9% from 2017 to 2022, to reach USD 5.31 billion by 2022. The key factors driving the growth of this market include growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, increasing investments and availability of funds for PCR-based research, and increasing use of biomarker profiling for disease diagnosis. However, factors such as high cost of dPCR products and technical limitations associated with qPCR and dPCR are restraining the growth of this market.
“The dPCR technology segment to grow at faster pace than qPCR technology segment during the forecast period.”
Based on the type of technology, the dPCR and qPCR market is classified into digital PCR (dPCR) and quantitative PCR (qPCR). In 2017, the qPCR technology segment is expected to account for the largest share of the market. However, the dPCR technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the ongoing technological developments in dPCR, significant adoption of dPCR products among target end users, expansion of distribution networks of emerging dPCR product manufacturers, and growing private funding for the development and commercialization of innovative dPCR instruments.
“The dPCR instruments segment is expected to grow at the highest CAGR during 2017-2022.”
On the basis of product and service, the dPCR and qPCR market is categorized into instruments; reagents and consumables; and software and services. The dPCR instruments segment is expected to witness the highest growth during the forecast period. The growth of this segment is mainly due to the procedural benefits of dPCR over qPCR, growing market demand for dPCR procedures (particularly in forensics and drug discovery), and rising number of dPCR-based researches across the globe.
“Asia-Pacific to witness the highest growth during the forecast period (2017-2022)”
North America is expected to hold the largest share of the global dPCR and qPCR market in 2017, followed by Europe. However, the Asia-Pacific region is expected to grow at the fastest rate during the forecast period. Growing awareness of physicians & healthcare professionals about the benefits of gene-based disease diagnosis and treatment, growing public-private support to develop novel dPCR and qPCR technologies, strong growth witnessed by the Indian genomics industry, and advancing cancer research in Japan are the key factors responsible for the growth of this market in the Asia-Pacific region.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–45%, Tier 2–34% and Tier 3–21%
• By Designation – Director Level–14%, C-level–10%, Others–76%
• By Region – North America–40%, Europe–32%, Asia-Pacific–20%, RoW–8%
Some of the major market players in the dPCR and qPCR market are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (U.S.), Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Fluidigm Corporation (U.S.), Danaher Corporation (U.S.), and Abbott Laboratories (U.S.), among others.
This report studies the dPCR and qPCR market based on technology, product and service, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report forecasts the revenue of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. The dPCR and qPCR market report profiles key players who are involved in the manufacturing and commercialization of dPCR and qPCR products and analyzes their core competencies. The report tracks and analyzes competitive developments such as new product launches and enhancements; mergers and acquisition; partnerships, collaborations and agreements; and expansions in the dPCR and qPCR market.
Reasons to Buy the Report:
From an insight perspective, this research report focuses on various levels of analysis—market share analysis of the top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the dPCR and qPCR market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the top 10 players in the dPCR and qPCR market. The report analyzes the Digital PCR (dPCR) and qPCR market by technology, product and service, application, end user, and region
• Product Development/Innovation: Detailed insights on research and development activities, developmental pipeline, and new product launches in the dPCR and qPCR market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various dPCR and qPCR products across four geographies (North America, Europe, Asia-Pacific, and the Rest of the World)
• Competitive Assessment: Assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the dPCR and qPCR market